Filing Details
- Accession Number:
- 0001127602-12-011826
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-03-26 16:43:03
- Reporting Period:
- 2012-03-22
- Filing Date:
- 2012-03-26
- Accepted Time:
- 2012-03-26 16:43:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 884731 | Ariad Pharmaceuticals Inc | ARIA | Biological Products, (No Disgnostic Substances) (2836) | 223106987 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1403174 | F Pierre Dodion | C/O Ariad Pharmaceuticals, Inc. 26 Landsdowne Street Cambridge MA 02139 | Svp, Corp. Dev. & Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-03-22 | 20,333 | $0.00 | 97,133 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-03-23 | 8,133 | $15.41 | 89,000 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-03-23 | 13,718 | $15.41 | 75,282 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-03-23 | 3,050 | $14.41 | 72,232 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2012-03-22 | 20,333 | $0.00 | 20,333 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 20,333 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 0 | Indirect | Wife |
Footnotes
- Shares were acquired upon vesting of restricted stock units awarded on March 22, 2010.
- Represents shares sold to satisfy withholding tax requirements related to the vesting of restricted stock units. Shares were sold pursuant to a Rule10b5-1 trading plan adopted by the reporting person on December 22, 2011.
- Each restricted stock unit represents a right to receive one share of ARIAD common stock.
- The restricted stock units vested on March 22, 2012.
- These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2011.
- These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2011.
Billionaire Hedge Funds
